Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Etiology of multiple sclerosis].

C Confavreux1, B Goudable, T Moreau

  • 1Clinique de neurologie, hôpital neurologique, Lyon.

La Revue Du Praticien
|September 15, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-metastatic breast cancer patients discontinuing aromatase inhibitor on denosumab: what next?

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same author

Neurodegeneration, oxidative stress and lipid metabolism plasma biomarkers to differentiate Parkinson's disease from atypical parkinsonian syndromes.

Revue neurologique·2023
Same author

A decade of fingolimod in multiple sclerosis: Insights from a large real-world cohort study.

Revue neurologique·2023
Same author

Erythema ab igne after using a virtual reality headset: a new phenomenon to know.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.

BMC medical research methodology·2022
Same author

Health related quality of life and perceived social support in French and Lebanese MS patients: A comparative study.

Multiple sclerosis and related disorders·2022
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Multiple Sclerosis (MS) risk involves environmental and genetic factors, with immunological abnormalities playing a role. The exact cause remains unknown, but it may be a post-infectious autoimmune disease.

Area of Science:

  • Neuroimmunology
  • Epidemiology
  • Genetics

Context:

  • Multiple Sclerosis (MS) is a chronic neurological disease.
  • Its etiology is multifactorial, involving genetic predisposition and environmental triggers.
  • Immunological dysfunction is a hallmark of MS, but direct causality is debated.

Purpose:

  • To explore the complex etiology of Multiple Sclerosis.
  • To discuss the interplay between genetic, environmental, and immunological factors.
  • To evaluate current theories on MS pathogenesis, including autoimmune and infectious origins.

Summary:

  • MS development is influenced by combined environmental and endogenous factors.
  • While immunological abnormalities are present, their direct role in myelin damage is unproven.

Related Experiment Videos

  • The pathogenesis remains elusive, with autoimmune and infectious theories being plausible, possibly as a post-infectious autoimmune condition.

    • Impact:

    • Highlights the need for further research into MS pathogenesis.
    • Underscores the complexity of MS etiology, integrating multiple contributing factors.
    • Informs potential future therapeutic strategies targeting the disease's origins.